subject_id=OCCAMS/ZZ/004;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/155;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/160;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/027;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/108;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/051;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/001;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/008;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/003;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/003;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/001;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/001;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/030;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/008;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/140;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/061;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/120;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/041;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/131;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/136;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/003;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/030;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/008;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/062;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/022;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/014;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/167;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/143;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/035;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/183;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/QE/095;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/064;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/085;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/021;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/009;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/016;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/077;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/042;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/048;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/046;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/021;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/007;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/071;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/135;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/043;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/041;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/028;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/146;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/029;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/036;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/010;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/133;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/007;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/006;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/027;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/028;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/146;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/029;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/006;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/009;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/019;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/020;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/112;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/001;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/005;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/006;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/009;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/019;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/020;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/033;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/035;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/036;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/037;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/063;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/063;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/174;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/196;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/197;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/213;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/047;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/174;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/196;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/197;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/213;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/047;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/012;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/012;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/014;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/013;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/013;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/014;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/023;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/011;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/014;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/047;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/071;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/023;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/011;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/036;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/039;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/064;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/082;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/085;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/088;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/003;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/020;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/024;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/008;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/061;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/120;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/041;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/029;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/131;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/139;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/029;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/139;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/140;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/019;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/011;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/062;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/022;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/014;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/167;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/143;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/019;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/011;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/GS/002;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/024;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/031;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/036;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/032;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/091;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/183;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/182;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/QE/095;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/035;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/GS/002;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/024;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/031;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/036;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/032;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/091;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/182;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/036;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/039;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/082;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/086;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/088;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/003;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/020;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/024;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/008;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/127;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/173;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/127;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/173;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/007;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/004;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/009;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/016;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/077;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/042;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/048;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/046;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/036;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/010;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/133;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/007;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/006;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/108;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/071;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/135;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/043;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/041;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/155;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/160;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/096;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/038;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/002;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/005;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/033;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/035;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/036;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/037;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/096;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/038;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/051;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/002;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/112;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/008;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/002;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/002;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/015;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/015;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/014;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/047;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/071;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/086;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/136;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/003;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
